Theurillat Group

Theurillat Group

We aim to explore the role of SPOP and CHD1 mutations to develop new therapeutic avenues for prostate cancer.

Alimonti group

Alimonti group

Our research is focused on the characterization of a novel type of cellular senescence response for cancer therapy

Catapano group

Catapano group

We investigate strategies aimed at blocking selectively transcription of genes that might be implicated in pathogenesis of cancer

Bertoni group

Bertoni group

We apply genomics techniques followed by functional studies to elucidate the lesions underlying non-Hodgkin’s lymphomas

About

The lOR Institute of Oncology Research is part of the Research Division of the Oncology Institute of Southern Switzerland (IOSI), the comprehensive cancer center of the Ente Ospedaliero Cantonale (EOC), and is the main facility for basic and translational research at the IOSI. The Institute was established in 2003 formerly as the IOSI Laboratory of Experimental Oncology and is located within the Institute for Research in Biomedicine (IRB) in Bellinzona, Canton Ticino. The Institute currently employs about 50 researchers. The Institute is directed by Carlo Catapano MD, PhD and comprises different groups working in the areas of tumor biology, genomics, molecular oncology and experimental therapeutics. The expertise available in the Institute spans from cell and molecular biology to molecu...

Read More

news

[open position] Postdoc in lymphoma genetics
18 Jan 2016

[open position] Postdoc in lymphoma genetics

The Lymphoma and Genomics Research Program at the Institute of Oncology Research (IOR) is seeking a ...
[closed] Position for research assistant in lymphoma genomics
27 Aug 2015

[closed] Position for research assistant in lymphoma genomics

  *** THIS POSITION IS CLOSED ***   The Lymphoma and Genomics Research Program he...

Director’s foreword

Mission statement

Cancer Research